Home›Search›Theranostics

Theranostics

Ivyspring International Publisher · Australia · Est. 1954

ISSN1838-7640eISSN1838-7640

✓ WOS SCIE✓ Scopus / SJR✓ DOAJ✓ Open Access

/ 100

High Trust

PubScope credibility score from verifiable indexing & ethics signals

Score Breakdown

◆ WoS flagship (SCIE/SSCI/AHCI)78

✓ Corroboration (3 more)+18

Total96

Level data: Norwegian Register (HK-dir), NLOD 2.0. · Third-party records · how this is calculated · Report an error →

⚡ Speed vs Prestige

How does this journal balance review speed with impact level?

weeks to publish · journal-reported

Average · vs ~15 wk median

Impact Factor & Quartile · Web of Science (JCR)

✓ Indexed in the Web of Science Core Collection (SCIE) — Clarivate publishes an official Journal Impact Factor and JCR quartile for this journal.

See the official Impact Factor & quartile on the journal’s page ↗

The Impact Factor & JCR quartile are licensed by Clarivate — we link you to the official source instead of reprinting a number that can go out of date. Source: Clarivate Journal Citation Reports.

H-Indexi

221

CiteScore

View ↗

Scopus metric · on the journal’s page

SNIPi

2.179

Total Worksi

5,472

Total Citationsi

346,578

2yr Mean Citednessi

9.80

Open Impact Factor alternative

Retractions

Source: Retraction Watch

Aims & Scope

Theranostics publishes innovative research articles reflecting the fields of in vitro diagnostics and prognostics, in vivo molecular imaging, molecular therapeutics, image-guided therapy, biosensors, system biology and translational medicine, personalized medicine and a broad spectrum of biomedical research that can be applied to future theranostic applications. Theranostics is a multidisciplinary journal that publishes innovative and original research articles reflecting fields of in vitro diagnostics and prognostics, in vivo molecular imaging, molecular therapeutics, image-guided therapy, biosensor, nanobiosensor and bioelectronics, system biology and translational medicine, point-of-care and personalized medicine. A broad spectrum of biomedical research that can be applied to future theranostic applications is encouraged. In addition to primary research, Theranostics also publishes reviews, news, and commentary to understand and bridge the gap among the laboratory, clinic, and biotechnology industries. Papers in the journal are rigorously peer-reviewed.

General Information

Country / RegionAustralia

Primary LanguageEnglish

1st Year Published1954

Annual Volume~ 454 articles / year

StatusActive (last: 2026)

Total Publications5,472

Publisher OrgIvyspring International Publisher

OA Since2010

Visit Journal Website

Submission Info

APC CostA$5,000

Peer ReviewPeer review

Review Time~12 weeks

Acceptance Rate—

OA LicenseCC BY

OA Rate—

Ethics & Quality

COPE Member✗ No

OASPA Member✗ No

Not on Predatory Lists✓ Yes

Plagiarism Detection✓ Yes

📦 Long-term Preservation

PMC

Think.Check.Submit Compliance

thinkchecksubmit.org

11/12 · 92%

✅

Do you know the journal / publisher?

Ivyspring International Publisher

✅

Does the journal have a website?

✓ Linked

✅

Is the ISSN verified?

1838-7640 / 1838-7640

✅

Indexed in a trusted database?

WoS, Scopus, DOAJ, PubMed

✅

Peer review process documented?

Peer review

❌

Follows ethical publishing standards (COPE)?

N/A

✅

APC fees clearly disclosed?

A$5,000

✅

Not on predatory/blacklists?

✓ Clean

✅

Long-term digital preservation?

PMC

✅

Plagiarism detection in place?

Yes

✅

Listed in DOAJ (verified OA)?

DOAJ verified

✅

Primary language documented?

English

Based on the Think.Check.Submit framework by DOAJ, COPE & OASPA. All data from verified open sources.

Publication & Citation Trend

Articles published

Citations received

612

53k

2019

868

72k

2020

534

40k

2021

448

24k

2022

332

13k

2023

458

10k

2024

571

4.3k

2025

221

150

2026

Source: OpenAlex · Each year’s green bar = citations earned by that year’s papers, counted to date — so recent years look lower simply because their papers haven’t had time to be cited yet.

SJR Quartile by Discipline

Scimago ranks this journal separately in each subject category — its quartile can differ by discipline.

Medicine (miscellaneous)Unranked

Pharmacology, Toxicology and Pharmaceutics (miscellaneous)Unranked

Subject Classification

Web of Science Categories

Medicine, Research & Experimental

Scopus Categories

Medicine (miscellaneous)Pharmacology, Toxicology and Pharmaceutics (miscellaneous)

Research Topics (OpenAlex)

Nanoplatforms for cancer theranosticsNanoparticle-Based Drug DeliveryExtracellular vesicles in diseaseMicroRNA in disease regulationRNA Interference and Gene DeliveryAdvanced biosensing and bioanalysis techniquesRNA modifications and cancerCancer-related molecular mechanisms researchCancer, Hypoxia, and MetabolismPhotoacoustic and Ultrasonic Imaging

Frequently asked questions about Theranostics

Is Theranostics a predatory journal?

PubScope has no integrity flags on record for Theranostics: it is indexed in Web of Science, Scopus, DOAJ, and is not on DOAJ's withdrawn list. Its PubScope Trust Score is 96/100. Indexing is a transparency signal, not a guarantee — always confirm fit and policies before submitting.

What is the impact factor of Theranostics?

Theranostics is indexed in the Web of Science Core Collection, so Clarivate publishes an official Journal Impact Factor for it (since the 2023 Journal Citation Reports, every Core Collection journal — including Arts & Humanities and Emerging Sources titles — receives one). PubScope links to Clarivate's official source rather than reprinting the number, which can be out of date. Its open 2-year mean citedness is 9.80.

Is Theranostics indexed in Scopus and Web of Science?

Theranostics is indexed in Web of Science, Scopus, DOAJ.

What is the aims and scope of Theranostics?

How much does it cost to publish in Theranostics?

Theranostics charges an article processing charge (APC) of about A$5,000 for open-access publication.